Yüklüyor......
Targeting oncogenic Notch signaling with SERCA inhibitors
P-type ATPase inhibitors are among the most successful and widely prescribed therapeutics in modern pharmacology. Clinical transition has been safely achieved for H(+)/K(+) ATPase inhibitors such as omeprazole and Na(+)/K(+)-ATPase inhibitors like digoxin. However, this is more challenging for Ca(2+...
Kaydedildi:
| Yayımlandı: | J Hematol Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789735/ https://ncbi.nlm.nih.gov/pubmed/33407740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-01015-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|